ERBB2 and breast carcinoma: PLAUR was observed to have a strong positive association with risk for breast cancer overall [odds ratio per standard deviation increment (OR): 2.27, 95% CI: 1.88 to 2.74; PP4: 0.99] and all molecular subtypes except HER2 enriched tumours.